SciELO - Scientific Electronic Library Online

 
vol.29 número1Diagnóstico de la Enfermedad de Chagas congénito: Aspectos relevantesControversias en radioterapia adyuvante en cáncer de próstata localizado índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Médica de Risaralda

versión impresa ISSN 0122-0667

Resumen

UEDA, Risa  y  KATAOKA, Hiromitsu. The potential of the antiplatelet agent ticagrelor as a new antibacterial agent. Revista médica Risaralda [online]. 2023, vol.29, n.1, pp.147-156.  Epub 29-Ago-2023. ISSN 0122-0667.  https://doi.org/10.22517/25395203.25126.

The number of deaths caused by drug-resistant bacteria is expected to increase in the future, and there is a need to develop new antimicrobial agents. Recently, the antiplatelet drug ticagrelor has been reported to have promising antibacterial properties. The purpose of this review is to analyze articles and case reports that describe the antimicrobial action of ticagrelor. Ticagrelor was found to have antibacterial reactions against Gram-positive bacteria, including drug-resistant and spore-forming bacteria, while no effect was observed against Gram-negative bacteria. In this paper we discuss a new potential antimicrobial agent, ticagrelor.

Palabras clave : Ticagrelor; pharmacology; antibacterial resistance; antiplatelet; MRSA; antibiotic.

        · texto en Inglés     · Inglés ( pdf )